Among patients with parkinsonian syndromes, plasma levels of total and phosphorylated Tau were significantly increased in all disease groups compared to controls, with the highest level in patients with FTD that in combination with Aβ42 could differentiate FTD from PD/APS with high accuracy (Lin et al. 2018a). The gene discussed is MAPT; the disease is Parkinson disease.